The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 12,401–12,500 of 31,469
Kawabe, H., MURATA, K., Shibata, H., Hirose, H., Tsujioka, M., Saito, I., & Saruta, T. (2000) · Hypertension Research · doi:10.1291/hypres.23.227 · Cited by 28
Francini, F., Castro, M. C., Gagliardino, J. J., & Massa, M. L. (2009) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y09-064 · Cited by 28
Vidal, J., Morı́nigo, R., Codoceo, V. H., et al. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0802921 · Cited by 28
Rull, A., García, R., Fernández-Sénder, L., García‐Heredia, A., Aragonès, G., Beltrán‐Debón, R., Marsillach, J., Alegret, J. M., Martín-Paredero, V., Mackness, B., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.11.021 · Cited by 28
Bağış, T., Gökçel, A., Zeyneloğlu, H. B., Tarım, E., Kılıçdağ, E. B., & Haydardedeoğlu, B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020294 · Cited by 30
Dietary PUFA and the metabolic syndrome in Indian Asians living in the UK
Brady, L. M., Williams, C. M., & Lovegrove, J. A. (2004) · Proceedings of The Nutrition Society · doi:10.1079/pns2003318 · Cited by 28
Increased electronegative charge of serum low-density lipoprotein in patients with diabetes mellitus
Yano, M., Inoue, M., Maehata, E., Shiba, T., Yamakado, M., Hirabayashi, Y., Taniyama, M., & Suzuki, S. (2003) · Clinica Chimica Acta · doi:10.1016/j.cccn.2003.09.020 · Cited by 28
Effect of treatment of overt hypothyroidism on insulin resistance
Nada, A. M. (2013) · World Journal of Diabetes · doi:10.4239/wjd.v4.i4.157 · Cited by 28
Bo, S., Ciccone, G., Baldi, I., Gambino, R., Mandrile, C., Durazzo, M., Gentile, L., Cassader, M., Cavallo‐Perin, P., & Pagano, G. (2008) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.09.001 · Cited by 26
Iafusco, D., Rea, F., Chiarelli, F., Mohn, A., & Prisco, F. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.712a · Cited by 28
Indirect lifestyle intervention through wives improves metabolic syndrome components in men
Matsuo, T., Kim, M. K., Murotake, Y., Numao, S., Kim, M. J., Ohkubo, H., & Tanaka, K. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.226 · Cited by 27
Parra, M. D., de Morentin, B. E. M., & Martínez, J. A. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602078 · Cited by 28
Effect of an 8-week resistance training program on cutaneous perfusion in type 2 diabetes
Colberg, S. R., Parson, H. K., Nunnold, T., Herriott, M. T., & Vinik, A. I. (2006) · Microvascular Research · doi:10.1016/j.mvr.2005.11.005 · Cited by 28
Factors associated with fasting plasma ghrelin levels in children and adolescents
Zou, C. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.790 · Cited by 26
Pimenta, A. M., Gazzinelli, A., & Velásquez-Meléndez, G. (2011) · Ciência & Saúde Coletiva · doi:10.1590/s1413-81232011000800029 · Cited by 28
Wadley, G. D., Konstantopoulos, N., Macaulay, L. S., Howlett, K. F., GARNHAM, A. P., Hargreaves, M., & Cameron‐Smith, D. (2006) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00821.2006 · Cited by 28
Selimoğlu, H., Duran, C., Kiyici, S. K., Güçlü, M., Ersoy, C., Özkaya, G., Ertürk, E., Tuncel, E., & İmamoğlu, Ş. (2009) · Endocrine · doi:10.1007/s12020-009-9213-z · Cited by 28
Metabolic syndrome and risk of pulmonary involvement
Rogliani, P., Curradi, G., Mura, M., et al. (2009) · Respiratory Medicine · doi:10.1016/j.rmed.2009.08.009 · Cited by 28
Lifestyle Intervention and Fatty Acid Metabolism in Glucose‐Intolerant Subjects
Mensink, M., Blaak, E. E., Wagenmakers, A. J. M., & Saris, W. H. M. (2005) · Obesity Research · doi:10.1038/oby.2005.164 · Cited by 28
Metabolic syndrome among Caribbean-born persons living in the U.S. Virgin Islands
Tull, E. S., Thurland, A., & LaPorte, R. E. (2005) · Revista Panamericana de Salud Pública · doi:10.1590/s1020-49892005001000005 · Cited by 28
Suzuki, K., Nakagawa, O., & Aizawa, Y. (2008) · Clinical and Experimental Hypertension · doi:10.1080/10641960802269927 · Cited by 28
The relationship between body fat and C-reactive protein in middle-aged Korean population
Lim, S. K., Jang, H. C., Lee, H. K., Kimm, K.-C., Park, C. Y., & Cho, N. H. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.04.003 · Cited by 27
Topçu, S., Çalışkan, M., Özçimen, E. E., Tok, D., Üçkuyu, A., Erdoğan, D., Güllü, H., Yı́ldı́rı́r, A., Zeyneloğlu, H. B., & Müderrisoğlu, H. (2005) · Human Reproduction · doi:10.1093/humrep/dei431 · Cited by 28
Karamanos, B. G., Thanopoulou, A. C., & Roussi, D. P. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00386.x · Cited by 28
Relationship between the adipose-tissue hormone resistin and coronary artery disease
Hoefle, G., Saely, C. H., Risch, L., et al. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.07.001 · Cited by 28
Gentile, M., Panico, S., Jossa, F., Mattiello, A., Ubaldi, S., Marotta, G., Pauciullo, P., & Rubba, P. (2007) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.10.033 · Cited by 28
Cosson, E., Bringuier, A. F., Pariès, J., et al. (2005) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70166-0 · Cited by 28
Mzayek, F., Sherwin, R. W., Fonseca, V. A., et al. (2004) · Annals of Epidemiology · doi:10.1016/j.annepidem.2003.09.014 · Cited by 28
Komatsu, M., Ohfusa, H., Aizawa, T., & Hashizume, K. (2007) · Endocrine Journal · doi:10.1507/endocrj.k07-032 · Cited by 28
Kawamura, T., Egusa, G., Okubo, M., Imazu, M., & Yamakido, M. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90145-2 · Cited by 28
Cardiovascular risk factors in Mexican-American children at risk for type 2 diabetes mellitus (T2DM)
Urrutia‐Rojas, X., Menchaca, J. T., Wadley, W., Ahmad, N., Lacko, A. G., Bae, S., Spellman, C., Kudchodkar, B. J., Kudolo, G. B., & McConathy, W. J. (2004) · Journal of Adolescent Health · doi:10.1016/j.jadohealth.2003.07.005 · Cited by 28
Changes in risk factors for cardiovascular disease with body fat loss in obese women
Krebs, J. D., Evans, S., Cooney, L. M., Mishra, G. D., Frühbeck, G., Finer, N., & Jebb, S. A. (2002) · Diabetes Obesity and Metabolism · doi:10.1046/j.1463-1326.2002.00231.x · Cited by 28
Andersen, L. B., Boreham, C. A., Young, I. S., Smith, G. D., Gallagher, A. M., Murray, L., & McCarron, P. (2005) · Preventive Medicine · doi:10.1016/j.ypmed.2005.10.009 · Cited by 28
Thomas, G. N., Tomlinson, B., Chan, J. C. N., Lee, Z. S. K., Cockram, C. S., & Critchley, J. (2000) · American Journal of Hypertension · doi:10.1016/s0895-7061(00)00265-x · Cited by 28
The Role of Vildagliptin in the Management of Type 2 Diabetes Mellitus
Kleppinger, E. L., & Helms, K. L. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h460 · Cited by 28
Zeghari, N., Vidal, H., Younsi, M. O., Ziegler, O., Drouin, P., & Donner, M. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.4.e736 · Cited by 29
Razny, U., Kiec-Wilk, B., Polus, A., Goralska, J., Malczewska-Malec, M., Wnek, D., Zdzienicka, A., Gruca, A., Childs, C. E., Kapusta, M., et al. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.05.001 · Cited by 27
Edmonds, E. C., Martin, A. S., Palmer, B. W., Eyler, L. T., Rana, B. K., & Jeste, D. V. (2018) · Aging & Mental Health · doi:10.1080/13607863.2016.1251572 · Cited by 27
Barreto Silva, M. I., Lemos, C. C. D. S., Torres, M. R. S. G., & Bregman, R. (2014) · Nutrition · doi:10.1016/j.nut.2013.08.004 · Cited by 27
The Effect of Casein Protein Prior to Sleep on Fat Metabolism in Obese Men
Kinsey, A., Cappadona, S., Panton, L., Allman, B., Contreras, R., Hickner, R., & Ormsbee, M. (2016) · Nutrients · doi:10.3390/nu8080452 · Cited by 28
Serum chemerin levels in Polycystic Ovary Syndrome after metformin therapy
Foda, A. A., Foda, E. A., El-Negeri, M. A., & El-Said, Z. H. (2019) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2019.01.050 · Cited by 27
Savastano, S., Di Somma, C., Angrisani, L., Orio, F., Longobardi, S., Lombardi, G., & Colao, A. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1476 · Cited by 34
Zhang, X., Liu, F., Li, W., Zhang, J., Zhang, T., Yu, X., Luo, J., Zhao, Q., Zhang, J., Fang, B., et al. (2023) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s404878 · Cited by 27
Association Between Insulin Resistance and Myosteatosis Measured by Abdominal Computed Tomography
Kim, M., Cho, Y. K., Jung, H. N., Kim, E. H., Lee, M. J., Jung, C. H., Park, J., Kim, H., & Lee, W. J. (2023) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgad382 · Cited by 27
Fiore, G., Scapaticci, S., Neri, C. R., Azaryah, H., Escudero-Marín, M., Pascuzzi, M. C., Mendola, A. L., Mameli, C., Chiarelli, F., Campoy, C., et al. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad122 · Cited by 29
Grigoriadis, G., Koufakis, T., & Kotsa, K. (2023) · Medicina · doi:10.3390/medicina59112013 · Cited by 33
Buga, A., Harper, D. G., Sapper, T. N., Hyde, P. N., Fell, B., Dickerson, R. M., Stoner, J. T., Kackley, M. L., Crabtree, C. D., Decker, D. D., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296523 · Cited by 26
Association between systemic immune-inflammation index and insulin resistance and mortality
Deng, X., Liu, D., Li, M., He, J., & Fu, Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-51878-y · Cited by 28
Han, S. K., Seo, M.-J., Lee, T., & Kim, M. Y. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303333 · Cited by 27
Yan, L., Zhou, Z., Wu, X., Qiu, Y., Liu, Z., Luo, L., Yang, Y., Lü, X., He, J., & Xia, W. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.16179 · Cited by 28
Wang, Z., Zhu, J., Xuan, S., Dong, S., Shen, Z., Chen, S., He, D., & Huang, H. Y. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02650-7 · Cited by 32
Oldenburg, N. C., Mashek, D. G., Harnack, L., Wang, Q., Manoogian, E. N. C., Evanoff, N. G., Dengel, D. R., Taddese, A., Yentzer, B. P., LYSNE, L. F., et al. (2025) · Obesity · doi:10.1002/oby.24252 · Cited by 29
Riffo, B., Asenjo, S., Sáez, K. L., et al. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2011.00834.x · Cited by 27
Gatto, N. M., Martinez, L. C., Spruijt‐Metz, D., & Davis, J. N. (2015) · Obesity · doi:10.1002/oby.21077 · Cited by 27
RetractedHypermetabolism and altered substrate oxidation in HIV-infected patients with lipodystrophy
Vassimon, H. S., de Paula, F. J. A., Machado, A. A., Monteiro, J. P., & Jordão, A. A. (2012) · Nutrition · doi:10.1016/j.nut.2011.12.010 · Cited by 27
Kwakernaak, A. J., Lambert, G. C., Kobold, A. C. M., & Dullaart, R. P. F. (2012) · Thyroid · doi:10.1089/thy.2012.0434 · Cited by 27
Grong, E., Arbo, I. B., Thu, O. K. F., Kuhry, E., Kulseng, B. E., & Mårvik, R. (2014) · Surgical Endoscopy · doi:10.1007/s00464-014-3732-2 · Cited by 26
Metabolic Issues in Schizophrenic Patients Receiving Antipsychotic Treatment
Gupta, A., Dadheech, G., Yadav, D., Sharma, P., & Gautam, S. (2014) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-013-0415-z · Cited by 27
Esteghamati, A., Ghasemiesfe, M., Mousavizadeh, M., Noshad, S., & Nakhjavani, M. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12157 · Cited by 27
Vaidya, D. M., Dobs, A. S., Gapstur, S. M., Golden, S. H., Cushman, M., Liu, K., & Ouyang, P. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.3 · Cited by 27
Luo, R., Li, X., Jiang, R., Gao, X., Lü, Z., & Hua, W. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000224 · Cited by 27
Normocalcemic Hyperparathyroidism and Insulin Resistance
Temizkan, Ş., Kocak, O., Aydın, K., Özderya, A., Arslan, G., Yücel, N., & Sargın, M. (2014) · Endocrine Practice · doi:10.4158/ep14195.or · Cited by 27
Short-term results of single-port sleeve gastrectomy in adolescents with severe obesity
Pourcher, G., FILIPPO, G. D., Ferretti, S., Piquard, C., Dagher, I., & Bougneres, P. F. (2014) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.05.029 · Cited by 26
Insulin resistance in nondiabetic patients with acute myocardial infarction
Nishio, K., Shigemitsu, M., Kusuyama, T., Fukui, T., Kawamura, K., Itoh, S., Konno, N., & Katagiri, T. (2006) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2005.12.004 · Cited by 27
Srivastava, N., Prakash, J., Mittal, B., & Awasthi, S. (2015) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.154773 · Cited by 27
Ng, A. C. M., Wai, D. C. H., Tai, E. S., Ng, K. M., & Chan, L. L. (2012) · Nutrition and Diabetes · doi:10.1038/nutd.2012.12 · Cited by 28
Mildly elevated blood pressure is a marker for better health status in Polish centenarians
Szewieczek, J., Duława, J., Francuz, T., et al. (2014) · AGE · doi:10.1007/s11357-014-9738-9 · Cited by 27
Oxidative stress contributes to muscle atrophy in chronic kidney disease patients
Beetham, K. S., Howden, E. J., Small, D. M., Briskey, D. R., Rossi, M., Isbel, N. M., & Coombes, J. S. (2014) · Redox Report · doi:10.1179/1351000214y.0000000114 · Cited by 27
Candesartan effect on inflammation in hypertension
Derosa, G., Maffioli, P., SALVADEO, S. A. T., Ferrari, I., Gravina, A., Mereu, R., Palumbo, I., D’Angelo, A., & Cicero, A. F. G. (2010) · Hypertension Research · doi:10.1038/hr.2009.212 · Cited by 27
Somma, C. D., Pivonello, R., Pizza, G., Rosa, A. D., Lombardi, G., Colao, A., & Savastano, S. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346577 · Cited by 27
Owais, A., Kabir, S. I., McNaught, C. E., Gatt, M., & MacFie, J. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2014.01.005 · Cited by 27
Tsuchimochi, W., Ueno, H., Yamashita, E., Tsubouchi, C., Sakoda, H., Nakamura, S., & Nakazato, M. (2014) · Endocrine Journal · doi:10.1507/endocrj.ej14-0393 · Cited by 27
Wickenberg, J., Lindstedt, S., Nilsson, J. Å., & Hlebowicz, J. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-96 · Cited by 27
Cicero, A. F. G., Rosticci, M., Parini, A., Morbini, M., Urso, R., Grandi, E., & Borghi, C. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0019-y · Cited by 27
Tam, C. H. T., Wang, Y., Luan, J., Lee, H. M., Luk, A. O. Y., Tutino, G., Tong, P. C. Y., Ko, G. T. C., Ozaki, R., Tam, W. H., et al. (2014) · Diabetic Medicine · doi:10.1111/dme.12630 · Cited by 27
SERUM LEPTIN IN THE DEVELOPMENT OF INSULIN RESISTANCE AND OTHER DISORDERS IN THE METABOLIC SYNDROME
Lichnovská, R., Gwozdziewiczová, S., Chlup, R., & Hřebíček, J. (2005) · Biomedical Papers · doi:10.5507/bp.2005.014 · Cited by 27
Obesity with and without metabolic syndrome: Do vitamin D and thyroid autoimmunity have a role?
Ağbaht, K., Mercan, Y., Kutlu, S., Alpdemir, M. F., & Sezgin, T. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.08.001 · Cited by 29
Bernsmeier, C., Calabrese, D., Heim, M. H., & Duong, F. H. T. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12208 · Cited by 26
Christie, D., Hudson, L. D., Mathiot, A., Cole, T. J., Karlsen, S., Kessel, A. S., Kinra, S., Stephen Morris, A., Nazareth, I., Sovio, U., et al. (2011) · Trials · doi:10.1186/1745-6215-12-242 · Cited by 27
Healy, L., Ryan, A. M., Pidgeon, G. P., Ravi, N., & Reynolds, J. V. (2010) · Diseases of the Esophagus · doi:10.1111/j.1442-2050.2010.01052.x · Cited by 27
Kindler, J. M., Pollock, N. K., Laing, E. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3451 · Cited by 27
Silva, J. C., de César, F. A., de Oliveira, E. M., Turato, W. M., Tripodi, G. L., Castilho, G., Machado‐Lima, A., Heras, B. D. L., Boscá, L., Rabello, M. M., et al. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.12.010 · Cited by 28
Çakır, M., Akbulut, U. E., & Ökten, A. (2016) · Childhood Obesity · doi:10.1089/chi.2015.0197 · Cited by 27
Vitamin D Supplementation Does Not Impact Insulin Resistance in Black and White Children.
Ferira, A. J., Laing, E., Hausman, D., Hall, D., McCabe, G., Martin, B., Gallant, K. H. H., Warden, S., Weaver, C., Peacock, M., et al. (2016) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jc.2015-3687 · Cited by 25
Bundalo, M., Živković, M., Romić, S., Tepavčević, S., Korićanac, G., Djurić, T., & Stanković, A. (2016) · Journal of the Renin-Angiotensin-Aldosterone System · doi:10.1177/1470320316642915 · Cited by 27
Sasaki, R., Yano, Y., Yasuma, T., Onishi, Y., Suzuki, T., Maruyama-Furuta, N., Gabazza, E. C., Sumida, Y., & Takei, Y. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.4100 · Cited by 27
Köroğlu, B. K., Kiris, F., Ersoy, İ. H., Sütçü, R., Yildiz, M., Aksu, O., Ermış, F., Ersoy, S., & Tamer, M. N. (2011) · PubMed · Cited by 26
FKBP5 polymorphism is associated with insulin resistance in children and adolescents with obesity
Fichna, M., Krzyśko-Pieczka, I., Żurawek, M., Skowrońska, B., Januszkiewicz‐Lewandowska, D., & Fichna, P. (2016) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2016.11.007 · Cited by 26
Hetherington-Rauth, M., Bea, J., Lee, V., Blew, R., Funk, J., Lohman, T., & Going, S. (2017) · Nutrix Journal · doi:10.1186/s12937-017-0236-7 · Cited by 26
Differences between Metabolically Healthy vs Unhealthy Obese Children and Adolescents
Khokhar, A., Chin, V. L., Perez-Colon, S., Farook, T., Bansal, S., Kochummen, E., & Umpaichitra, V. (2017) · Journal of the National Medical Association · doi:10.1016/j.jnma.2017.02.008 · Cited by 27
Pinto, R. M., Silva, D. D. M. E., de Queiroz, F. J., Godoy, F. R., Teodoro, L. D. S., Lacerda, I. C., Gonçalves, M. W., Pinto, I. P., Minasi, L. B., Gigonzac, T. C. V., et al. (2015) · Obesity Research - Open Journal · doi:10.17140/oroj-2-111 · Cited by 27
Vlaar, E. M., Nierkens, V., Nicolaou, M., Middelkoop, B. J., Busschers, W. B., Stronks, K., & van Valkengoed, I. G. M. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-012221 · Cited by 29
Postprandial VLDL-TG metabolism in type 2 diabetes
Søndergaard, E., Johansen, R. F., Jensen, M. D., & Nielsen, S. (2017) · Metabolism · doi:10.1016/j.metabol.2017.07.002 · Cited by 27
Esmaeilzadeh, S., Gholinezhad, M., & Ghadimi, R. (2017) · Journal of Human Reproductive Sciences · doi:10.4103/jhrs.jhrs_74_16 · Cited by 27
Association of Plasma Magnesium with Prediabetes and Type 2 Diabetes Mellitus in Adults
Chen, S., Jin, X., Liu, J., Sun, T., Xie, M., Bao, W., Yu, X., Yang, X., Zhang, Y., Zhang, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-13050-7 · Cited by 28
Effects of Two Training Modalities on Body Fat and Insulin Resistance in Postmenopausal Women
Henríquez, S., Monsalves‐Álvarez, M., Jimenez, T., Barrera, G., Hirsch, S., de la Maza, M. P., Leiva, L., Rodriguez, J. M., Silva, C., & Bunout, D. C. (2017) · The Journal of Strength and Conditioning Research · doi:10.1519/jsc.0000000000002089 · Cited by 26
Foss‐Freitas, M. C., Bannitz, R. F., Monteiro, L. Z., Gomes, P. M., Iwakura, R., de Freitas, L. C. C., & Foss, M. C. (2018) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0301-6 · Cited by 27
Serum adiponectin and insulin secretion: A direct or inverse association?
Nakamura, A., Miyoshi, H., Ukawa, S., Nakamura, K., Nakagawa, T., Terauchi, Y., Tamakoshi, A., & Atsumi, T. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12821 · Cited by 26
Kim, J., Kwon, H., Heo, B.-K., et al. (2018) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2018.39.2.74 · Cited by 27
Ursini, F., Russo, E., Ruscitti, P., Giacomelli, R., & Sarro, G. D. (2018) · Autoimmunity Reviews · doi:10.1016/j.autrev.2017.11.030 · Cited by 26
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
